Search research articles
Contact Us
Filters
Showing results (21-30 of 81) with videos related to
Page
of 9
Sort By:
Cancer
|
September 15, 1991
Disposition of high-dose methotrexate in an obese cancer patient
R A Fleming, R M Eldridge, C E Johnson, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1991
Relation of systemic exposure to unbound etoposide and hematologic toxicity
C F Stewart, S G Arbuck, R A Fleming, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1990
Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis
C F Stewart, R A Fleming, C R Arkin, et al.
Cancer Research
|
November 1, 1990
Prospective evaluation of a model for predicting etoposide plasma protein binding in cancer patients
C F Stewart, R A Fleming, S G Arbuck, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1987
Influence of concomitant aspirin or prednisone on methotrexate synovial fluid concentration
C F Stewart, M L Christensen, R P Evens, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Pharmacodynamics of three daily infusions of etoposide in patients with extensive-stage small-cell lung cancer
A A Miller, E A Tolley, H B Niell, et al.
Cancer Chemotherapy and Pharmacology
|
February 28, 2001
Effect of hemodialysis on topotecan disposition in a patient with severe renal dysfunction
J D Herrington, J A Figueroa, M N Kirstein, et al.
Arthritis and Rheumatism
|
December 1, 1991
Aspirin alters methotrexate disposition in rheumatoid arthritis patients
C F Stewart, R A Fleming, B F Germain, et al.
Cytometry
|
February 1, 1995
Cell cycle analysis of amount and distribution of nuclear DNA topoisomerase I as determined by fluorescence digital imaging microscopy
S D Baker, R M Wadkins, C F Stewart, et al.
Journal of Voice : Official Journal of the Voice Foundation
|
March 1, 1997
Adductor spasmodic dysphonia: standard evaluation of symptoms and severity
C F Stewart, E L Allen, P Tureen, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 81) with videos related to
Sort By:
Page
of 9
Cancer
|
September 15, 1991
Disposition of high-dose methotrexate in an obese cancer patient
R A Fleming, R M Eldridge, C E Johnson, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1991
Relation of systemic exposure to unbound etoposide and hematologic toxicity
C F Stewart, S G Arbuck, R A Fleming, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1990
Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis
C F Stewart, R A Fleming, C R Arkin, et al.
Cancer Research
|
November 1, 1990
Prospective evaluation of a model for predicting etoposide plasma protein binding in cancer patients
C F Stewart, R A Fleming, S G Arbuck, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1987
Influence of concomitant aspirin or prednisone on methotrexate synovial fluid concentration
C F Stewart, M L Christensen, R P Evens, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Pharmacodynamics of three daily infusions of etoposide in patients with extensive-stage small-cell lung cancer
A A Miller, E A Tolley, H B Niell, et al.
Cancer Chemotherapy and Pharmacology
|
February 28, 2001
Effect of hemodialysis on topotecan disposition in a patient with severe renal dysfunction
J D Herrington, J A Figueroa, M N Kirstein, et al.
Arthritis and Rheumatism
|
December 1, 1991
Aspirin alters methotrexate disposition in rheumatoid arthritis patients
C F Stewart, R A Fleming, B F Germain, et al.
Cytometry
|
February 1, 1995
Cell cycle analysis of amount and distribution of nuclear DNA topoisomerase I as determined by fluorescence digital imaging microscopy
S D Baker, R M Wadkins, C F Stewart, et al.
Journal of Voice : Official Journal of the Voice Foundation
|
March 1, 1997
Adductor spasmodic dysphonia: standard evaluation of symptoms and severity
C F Stewart, E L Allen, P Tureen, et al.
Page
of 9